Pharma stocks plunge as Trump’s 100% tariffs send shockwaves across Asia.

Hosted by Michelle Martin, we break down the impact on Singapore’s $4 billion pharma exports, Sumitomo Pharma, CSL, and more. Are these tariffs a short-term blow or a long-term reset for Asian healthcare investments?

Plus, we spotlight Mapletree’s three Singapore REITs - Logistics, Industrial, and Pan-Asia Commercial - amid expected rate cuts. 

Which one offers the best dividend yield and growth potential?

Dividend Titan’s Willie Keng shares his strategy for navigating healthcare risks and REIT opportunities.  

See omnystudio.com/listener for privacy information.